Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1985 1
1987 3
1988 10
1989 3
1990 9
1991 9
1992 7
1993 8
1994 12
1995 5
1996 4
1997 4
1998 7
1999 6
2000 4
2001 6
2002 9
2003 11
2004 6
2005 7
2006 15
2007 10
2008 15
2009 15
2010 17
2011 27
2012 13
2013 37
2014 57
2015 55
2016 53
2017 70
2018 70
2019 75
2020 85
2021 83
2022 97
2023 89
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

924 results

Results by year

Filters applied: . Clear all
Page 1
A Good Death?
Leiter RE. Leiter RE. N Engl J Med. 2021 Oct 14;385(16):1448-1449. doi: 10.1056/NEJMp2107941. Epub 2021 Oct 9. N Engl J Med. 2021. PMID: 34623785 No abstract available.
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma.
Vokes NI, Chambers E, Nguyen T, Coolidge A, Lydon CA, Le X, Sholl L, Heymach JV, Nishino M, Van Allen EM, Jänne PA. Vokes NI, et al. J Thorac Oncol. 2022 Jun;17(6):779-792. doi: 10.1016/j.jtho.2022.02.011. Epub 2022 Mar 21. J Thorac Oncol. 2022. PMID: 35331964 Free PMC article.
METHODS: In this retrospective study, targeted next-generation sequencing data were collected from patients with EGFR-mutant lung cancer treated at the Dana-Farber Cancer Institute. Clinical data were collected and correlated with somatic mutation data. ...Further investig …
METHODS: In this retrospective study, targeted next-generation sequencing data were collected from patients with EGFR-mutant lung cancer tre …
Pressure ulcer risk assessment and prevention: a systematic comparative effectiveness review.
Chou R, Dana T, Bougatsos C, Blazina I, Starmer AJ, Reitel K, Buckley DI. Chou R, et al. Ann Intern Med. 2013 Jul 2;159(1):28-38. doi: 10.7326/0003-4819-159-1-201307020-00006. Ann Intern Med. 2013. PMID: 23817702 Free article. Review.
DATA EXTRACTION: Multiple investigators abstracted and checked study details and quality using predefined criteria. DATA SYNTHESIS: One good-quality trial found no evidence that use of a pressure ulcer risk assessment instrument, with or without a protocolized intervention …
DATA EXTRACTION: Multiple investigators abstracted and checked study details and quality using predefined criteria. DATA SYNTHESIS: One g …
Individual and social determinants of COVID-19 vaccine uptake.
Viswanath K, Bekalu M, Dhawan D, Pinnamaneni R, Lang J, McLoud R. Viswanath K, et al. BMC Public Health. 2021 Apr 28;21(1):818. doi: 10.1186/s12889-021-10862-1. BMC Public Health. 2021. PMID: 33910558 Free PMC article.
CONCLUSIONS: Our study identified race/ethnicity, risk perceptions, exposure to different media for COVID-19 news, party identification and confidence in scientists as factors that would be affecting COVID-19 vaccine uptake. The good news is that these are addressable thro …
CONCLUSIONS: Our study identified race/ethnicity, risk perceptions, exposure to different media for COVID-19 news, party identification and …
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy.
Kaczanowska S, Murty T, Alimadadi A, Contreras CF, Duault C, Subrahmanyam PB, Reynolds W, Gutierrez NA, Baskar R, Wu CJ, Michor F, Altreuter J, Liu Y, Jhaveri A, Duong V, Anbunathan H, Ong C, Zhang H, Moravec R, Yu J, Biswas R, Van Nostrand S, Lindsay J, Pichavant M, Sotillo E, Bernstein D, Carbonell A, Derdak J, Klicka-Skeels J, Segal JE, Dombi E, Harmon SA, Turkbey B, Sahaf B, Bendall S, Maecker H, Highfill SL, Stroncek D, Glod J, Merchant M, Hedrick CC, Mackall CL, Ramakrishna S, Kaplan RN. Kaczanowska S, et al. Cancer Cell. 2024 Jan 8;42(1):35-51.e8. doi: 10.1016/j.ccell.2023.11.011. Epub 2023 Dec 21. Cancer Cell. 2024. PMID: 38134936
Since CAR-T efficacy requires adequate CAR-T expansion, patients were grouped into good or poor expanders across dose levels. Patient samples were evaluated by multi-dimensional proteomic, transcriptomic, and epigenetic analyses. T cell assessments identified naive T cells …
Since CAR-T efficacy requires adequate CAR-T expansion, patients were grouped into good or poor expanders across dose levels. Patient …
Good vibrations-better care for lung cancer patients.
Swanson SJ. Swanson SJ. J Thorac Cardiovasc Surg. 2019 Jan;157(1):378-379. doi: 10.1016/j.jtcvs.2018.04.022. Epub 2018 Apr 13. J Thorac Cardiovasc Surg. 2019. PMID: 29730113 Free article. No abstract available.
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.
Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA. Chou R, et al. Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559. Ann Intern Med. 2015. PMID: 25581257 Free article. Review.
DATA SYNTHESIS: No study of opioid therapy versus no opioid therapy evaluated long-term (>1 year) outcomes related to pain, function, quality of life, opioid abuse, or addiction. Good- and fair-quality observational studies suggest that opioid therapy for chronic pain i …
DATA SYNTHESIS: No study of opioid therapy versus no opioid therapy evaluated long-term (>1 year) outcomes related to pain, function, qua …
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?
Kuczmarski TM, Odejide OO. Kuczmarski TM, et al. Curr Hematol Malig Rep. 2021 Apr;16(2):117-125. doi: 10.1007/s11899-021-00629-1. Epub 2021 Apr 16. Curr Hematol Malig Rep. 2021. PMID: 33864180 Free PMC article. Review.
PURPOSE OF REVIEW: The medical field has a critical role not only in prolonging life but also in helping patients achieve a good death. Early studies assessing end-of-life quality indicators to capture if a good death occurred demonstrated low rates of hospice use a …
PURPOSE OF REVIEW: The medical field has a critical role not only in prolonging life but also in helping patients achieve a good deat …
Accelerating inhibitor discovery for deubiquitinating enzymes.
Chan WC, Liu X, Magin RS, Girardi NM, Ficarro SB, Hu W, Tarazona Guzman MI, Starnbach CA, Felix A, Adelmant G, Varca AC, Hu B, Bratt AS, DaSilva E, Schauer NJ, Jaen Maisonet I, Dolen EK, Ayala AX, Marto JA, Buhrlage SJ. Chan WC, et al. Nat Commun. 2023 Feb 8;14(1):686. doi: 10.1038/s41467-023-36246-0. Nat Commun. 2023. PMID: 36754960 Free PMC article.
Optimization of an azetidine hit yields a probe for the understudied DUB VCPIP1 with nanomolar potency and in-family selectivity. Our success in identifying good chemical starting points as well as structure-activity relationships across the gene family from a modest but p …
Optimization of an azetidine hit yields a probe for the understudied DUB VCPIP1 with nanomolar potency and in-family selectivity. Our succes …
p53: good cop/bad cop.
Sharpless NE, DePinho RA. Sharpless NE, et al. Cell. 2002 Jul 12;110(1):9-12. doi: 10.1016/s0092-8674(02)00818-8. Cell. 2002. PMID: 12150992 Free article. Review.
Here, we discuss the significant participation of p53 in three non-mutually exclusive theories of human aging involving DNA damage, telomere shortening, and oxidative stress. These "good cop/bad cop" functions of p53 appear to place it at the nexus of two opposing forces, …
Here, we discuss the significant participation of p53 in three non-mutually exclusive theories of human aging involving DNA damage, telomere …
924 results